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The rate of release from multilamellar liposomes of the fluoroscent probe carboxyfluorescein was de- 
termined as a measure of membrane permeability. Liposomes of phosphatidylcholine and different anionic 
phospholipids were incubated with low (I pM) and high (3 mM) concentrations of calcium in the absence or 
presence of aminoglycoside antibiotics. The leakage of carboxytluorescein into the medium was not caused 
by liposomal fusion as no vesicle fusion was observed in experiments with terbium and dipicolinic 
acid-loaded liposomes. The basal rate of carboxyfluorescein release (in the absence or presence of I /~M 
calcium) from all types of liposomes ranged from 0.1 to 0.3% of trapped carboxyfluorescein per hour. The 
presence of 3 mM calcium caused the greatest increase in the rate of carboxyfluorescein release (about 
9-fold) in iiposomes containing phospbatidylinositol 4,5-bisphosphate (PIP z) whereas liposomes containing 
the other anionic phospholipids (pbosphatidyiserine, phosphatidylinositoi and phosphatidylinositol 4-phos- 
pbate) showed an approximate 5-fold increase. In the presence of 1 pM calcium, the aminoglycosides 
neomycin and gentamicin also increased the rate of carboxyfluorescein release, with PIPz-containing 
liposomes showing a 3-5-times greater response than the other liposomes, releasing up to 4.6% of trapped 
carboxyfluorescein per hour. This drug-induced release was dose-dependent and antagonized by calcium. In 
the presence of 3 mM calcium, 0.1 mM gentamicin or neomycin were ineffective while the drug at 1 mM 
affected carboxyfluorescein release from PIPz-liposomes only. The aminoglycoside antibiotics, neomycin, 
gentamicin, tobramycin, kanamycin, amikacin, netilmicin, as well as neamine and spectinomycin (all at 0.1 
raM) showed a graded effect on the rate of carboxyfluorescein release from PIPz-containing vesicles in the 
presence of 0.1 mM calcium. The magnitude of the effect correlated well with the ototoxicity of the drugs 
previously determined directly in cochlear perfusions in the guinea pig. The study demonstrates that 
aminoglycoside antibiotics are capable of altering membrane permeabilities and that this effect is most 
pronounced if PIP 2 is present in the bilayers. The excellent correlation between this membrane action and 
the in-situ toxicity of the drugs further establishes the specific role of PIP z in the molecular mechanism of 
aminoglycoside-induced hearing loss. Moreover, it confirms the usefulness of such physicocbemical models 
for the screening and prediction of aminoglycoside toxicity. 
Introduction 
Interactions of aminoglycoside antibiotics with 
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components of the cell membrane are well docu- 
mented as part of their toxic actions. Competition 
with calcium underlies the acute neuromuscular 
blockade [1] as well as the acute depression of the 
microphonic potential of the inner ear [2]. 
Antagonism with calcium and magnesium has also 
been reported for these drugs at the bacterial 
plasma membrane [3]. 
In addition to this displacement of calcium 
from membrane binding sites, specific interactions 
of the aminoglycoside with the membrane lipid 
phosphatidylinositol 4,5-bisphosphate (PIP2) have 
been documented. The drugs inhibit the metabo- 
lism of the lipid both in vitro [4] and in vivo in the 
tissues which are susceptible to their adverse toxic 
actions, i.e., inner ear [5] and kidney [6]. The 
binding of the aminoglycosides to PIP 2 which un- 
derlies the metabolic effects shows a number of 
unique physicochemical characteristics that are not 
seen with other phospholipids. The aminoglyco- 
side-PIP2 interaction creates an area-determining 
complex in lipid monolayers [7]; it raises the tran- 
sition temperature [8] and causes phase separation 
of lipid components in liposomes [9]. Since the 
magnitude of these effects correlates well with the 
intrinsic ototoxicity of a series of aminoglycoside 
antibiotics, we have suggested that this interaction 
is a crucial step in determining toxicity of these 
drugs [7,10]. 
While the earlier studies clearly demonstrated 
alterations of membrane structure as a result of 
aminoglycoside-PIP2 binding, the potential conse- 
quences for the integrity of the membrane bilayer 
remained to be established. The effect of drugs on 
the integrity of membranes is conveniently mea- 
sured in lipid vesicles with the water-soluble fluo- 
rescent marker carboxyfluorescein. Its fluores- 
cence is self-quenched during containment in lipo- 
somes and leakge into the surrounding medium 
can be continuously and sensitively monitored as 
an increase in fluorescence due to the dilution of 
the marker [11]. The present study examines the 
influence of aminoglycosides on the rate of efflux 
of carboxyfluorescein from liposomes of different 
composition. 
Materials and Methods 
L-a-Phosphatidylcholine (PC, from frozen egg 
yolk), L-a-phosphatidylserine (PS), L-a-phos- 
phatidylinositol (PI), neomycin sulfate, spectin- 
omycin dihydrochloride, dipicolinic acid (DPA, 
pyridine-2,6-dicarboxylic acid), sodium citrate, 
Triton X-100 and ethylenediaminetetraacetic acid 
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(EDTA) were purchased from Sigma Chemical 
Co., St. Louis, MO; terbium chloride (TbC13, 
99.9% pure) from Alfa Products, Danvers, MS; 
Sephadex LH-20 from Pharmacia, Piscataway, NJ. 
Gentamicin sulfate and netilmicin sulfate were 
supplied by the Schering Corp. (Bloomfield, N J); 
amikacin and kanamycin by Bristol Laboratories 
(New York, NY); tobramycin from the Eli Lilly 
Company, Indianapolis, IN; and neamine from 
the Upjohn Company, Kalamazoo, MI. Phos- 
phatidylinositol 4-phosphate (PIP) and phos- 
phatidylinositol 4,5-bisphosphate (PIP2) were iso- 
lated from Sigma brain extracts (Cat. No. P6023) 
by chromatography on immobilized neomycin [12]. 
Lipids were stored in the dark under nitrogen at 
- 2 0  o C; PIP and PIP 2 were dried and the other 
lipids were kept dissolved in chloroform. The pur- 
ity of the lipids was greater than 98% as estimated 
by thin-layer chromatography (TLC). The water 
was thrice distilled, the second and third time in 
an all-glass apparatus. Crude carboxyfluorescein 
(Eastman Kodak, Rochester, NY) was purified by 
the method described by Ralston et al. [13]. The 
resultant carboxyfluorescein showed no impurities 
by TLC. The buffer for all experiments was 0.05 
M Hepes (N-2-hydroxyethyl-l-piperazine-N'-2- 
ethanesulfo~c acid), pH 7.0; ionic strength 0.2, 
adjusted with sodium chloride. All other chemicals 
were of reagent grade. 
Preparation of liposomes. Chloroform solutions 
of the lipid mixtures contained in a 10-ml round- 
bottom flask were dried under nitrogen while the 
flask was rotated by hand to aid the formation of 
a uniformly thin lipid film at its bottom. Residual 
solvent was removed by storing the flask overnight 
under vacuum. The dried film was then suspended 
in buffer containing 100 mM carboxyfluorescein 
and the dispersion was vortexed intermittently for 
one hour at room temperature. The resultant 
phospholipid concentration was about 30 mM. 
Free carboxyfluorescein was removed by passage 
of the dispersion through a 1 × 45 cm column of 
Sephadex G-75 where the vesicles eluted with the 
void volume. 
Carboxyfluorescein studies. Aliquots of the lipo- 
somal stock preparations (diluted to about 5 mM) 
were incubated with various concentrations of 
calcium chloride or amlnoglycosides or both at 
room temperature and fluorescence was recorded 
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continuously for 8-10 hours. For experiments car- 
ried out in the absence of calcium, the incubation 
medium contained one mM EDTA. At the end of 
each experiment, total ~ carboxyfluorescein fluo- 
rescence was determined after lysing the hposomes 
with 0.1% Triton X-100 and mixing the sample 
vigorously for 5 rain at room temperature. 
Fluorescence measurements were made with a 
Perkin-Elmer, Model LS-5 spectrofluorometer (ex- 
citation and emission slit widths were 10 nm and 3 
nm, respectively). Carboxyfluorescein was excited 
at 490 nm and emission was read at 520 nm. All 
experiments were done in triplicate. 
Terbium-dipicolinic acid studies. The terbium-di- 
picolinic acid assay was based on the method 
described by Wilschut et al. [14]. Three popula- 
tions of multilamellar liposomes were prepared as 
described above from PC and an anionic phos- 
pholipid (PS or PIP2) at a molar ratio 4:1. The 
vesicles contained the following aqueous media in 
place of carboxyfluorescein: (I) 2.5 mM W b f l  3 
and 50 mM sodium citrate; (II) 50 mM DPA; and 
(III) 2.5 mM TbC13, 50 mM DPA and 50 mM 
sodium citrate. Vesicles were separated from non- 
encapsulated material by passage of the dispersion 
through a 1 × 45 cm column of Sephadex G-75. 
One mM EDTA was included in the ehition buffer 
for all the liposome preparations. 
Mixtures (1:1, v/v) of liposome preparations 
(I) and (II) were incubated with 1 mM calcium 
chloride or gentamicin (0.1 mM or 1.0 mM) or 
both in buffer at room temperature and fluores- 
cence measurements were carried out at various 
time intervals. The slit width was 10 nm for both 
excitation (275 nm) and emission (545 nm). Maxi- 
mum Tb fluorescence (that obtained upon com- 
plete fusion of the two liposome populations) was 
determined by measuring the fluorescence inten- 
sity of a quantity of liposome preparation (III) 
equal to that of the mixture of preparation (I) and 
(II). All experiments were done in triplicate. 
Results 
The rates of carboxyfluorescein (CF) leakage 
are expressed as per cent of total trapped CF 
released 
IF-Fo~ 
= × , o o  (1> 
where F is the fluorescence intensity measured at 
a specified time, F 0 at zero time, and F t the total 
fluorescence after Triton disruption. F t is cor- 
rected for the dilution introduced by the addition 
of Triton. Incubation of the liposomes with higher 
concentrations of Triton X-100 (1%) and at higher 
temperatures (60 ° C) did not affect the value of F t 
indicating that the procedure resulted in a com- 
plete release of dye from the liposomes. 
In order to determine the potential contribu- 
tion of vesicle fusion on the leakage of carboxy- 
fluorescein, liposomes of PC, PC/PS or PC/PIP  2 
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Fig. 1. Effects of drugs and calcium on carboxyfluorescein (CF) leakage from PIP2-containing liposomes. Aliquots of the liposomal 
stock preparations were incubated as described in Methods. (A) Effect of neomycin (m) and gentamicin ( 0 )  concentration on the rate 
of carboxyfluorescein release from liposomes in the presence of 1 gM calcium. (B) Effect of calcium concentration on the rate of 
carboxyfluorescein release from liposomes in the presence of 0.1 mM neomycin (~) or gentamicin (0 ) .  
TABLE I 
EFFECTS OF CALCIUM AND AMINOGLYCOSIDES ON 
RELEASE OF CARBOXYFLUORESCEIN 
Carboxyfluorescein release (% leakage/h) from mixed lipo- 
somes of PC plus the anionic lipid indicated (molar ratio, 4 : 1) 
was determined as described in Methods. 
Anionic Neo- Genta- Release at 
lipid mycin mycin 0 and 1 #M 3 mM 
(mM) (raM) Ca2+ Ca2+ 
PS 0 0 0.2 0.96 
PS 0.1 0 1.07 0.89 
PS 1.0 0 1.16 0.89 
PS 0 0.1 0,70 0.89 
PS 0 1,0 0.90 0,89 
PI 0 0 0.2 0.96 
PI 0.1 0 1.10 0.96 
PI 1.0 0 1.16 0.96 
PI 0 0.1 0.66 0.96 
P1 0 1.0 0.90 0.96 
PIP 0 0 0.2 1.10 
PIP 0.1 0 1.22 1.08 
PIP 1.0 0 1.27 1.08 
PIP 0 0.1 0.90 1,08 
PIP 0 1.0 1.00 1,08 
PIP 2 0 0 0.2 1.71 
PIP 2 0.1 0 3.62 2.02 
PIP 2 1.0 0 4.61 2.67 
PIP 2 0 0.1 2.91 1.75 
PIP 2 0 1.0 4.08 2.06 
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cubated with an equal aliquot containing dipico- 
linic acid. In the absence of cations, fluorescence 
intensity remained constant for at least 3 hours. 
Addition of calcium or gentamicin or both to any 
of the liposomes did not change the Tb fluores- 
cence significantly. Less than 0.25% of the maxi- 
mal fluorescence expected from liposome fusion 
was detected under these conditions. 
Preliminary experiments had indicated that 
liposomes at molar ratios of PC/anionic lipid of 
2 : 1 or 1 : 1 were very leaky to carboxyfluorescein 
resulting in high basal release values interfering 
with the determination of drug-induced changes. 
In contrast, leakage at molar ratios of 4:1 was 
minimal, the rate of earboxyfluorescein release 
from all liposomes tested ranged from 0.1 to 0.3% 
of trapped carboxyfluorescein per hour was essen- 
tially linear (r > 0.98) over 6 to 8 hours, i.e., the 
entire time course of the experiments. For lipo- 
somes of all compositions, the release rates were 
identical whether calcium was absent or present at 
1 btM. This included the release rates in the ad- 
ditional presence of aminoglycosides. 
The addition of 3 mM calcium resulted in 
significant increases of carboxyfluorescein release 
in all liposomes and particularly in PIP2-contain- 
ing liposomes which showed an approximate 8-fold 
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Fig. 2. Reversibility of the calcium-aminoglycoside interaction. Changes in the rate of carboxyfluorescein (CF) release upon 
sequential addition of calcium and drug were obtained as described in Methods. (A) Effect of 1 mM calcium on the rate of 
carboxyfluorescein release from PIP2-containing liposomes in the presence of 0.1 mM gentamicin. Key: (11) gentamicin alone, no 
calcium added; (+ )  gentamicin and calcium added at time zero; (A) gentamicin added at time zero, calcium at t = 2 h (arrow). (B) 
Effect of 0.1 mM gentamicin on the rate of carboxyfluorescein release from PIP2-containing liposomes in the presence of 1 mM 
calcium. Key: (A) calcium alone, no gentamicin added; (+ )  calcium and gentamicin added at time zero; (12) calcium added at time 
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Fig. 3. Effect of aminoglycoside antibiotics on carboxy- 
fluorescein (CF) leakage from glP2-containing liposomes. 
Aliquots of the liposomal stock preparations were incubated as 
described in Methods with 0.1 mM drug in the presence of 1 
~tM calcium. Key: (~) neomycin; (O) gentamicin and 
tobramycin (represented as a single curve for the sake of 
clarity); (~,) kanamycin, amikacin and netilmicin (represented 
as a single curve for the sake of clarity); ( ~ )  neamine; (11) 
spectinomycin. 
containing liposomes was also evident when lipo- 
somes were challenged with neomycin  or 
gentamicin. The addition of 0.1 mM aminoglyco- 
side was about as effective as 3 mM calcium 
across all liposomes in inducing carboxyfluor- 
escein leakage and the aminoglycoside was again 
most active against PIP 2 vesicles. The rates were 
further increased if the aminoglycoside concentra- 
tion was raised to 1 mM, and neomycin was more 
effective than gentamycin. For PIP 2 vesicles, the 
release rate was increased approximately 20-fold 
in the presence of 1 mM neomycin over that of the 
controls. 
In the presence of 1 #M calcium, the rate of 
carboxyfluorescein release from PIP 2 liposomes by 
neomycin or gentamicin was dose-dependent with 
neomycin somewhat more effective than gentami- 
cin (Fig. 1A). Both drugs significantly increased 
carboxyfluorescein release even at a concentration 
of 10 /~M. The competitive effect of calcium was 
also dose-dependent (Fig. 1B), and 10/~M calcium 
was the lowest effective concentration to antago- 
nize 0.1 mM drug. 
The effects of calcium and of aminoglycosides 
were not additive but competitive (Table I). This 
is indicated by the combinations of 0.1 mM and 1 
mM neomycin or gentamicin with 3 mM calcium. 
For example, 1 mM neomycin alone (or in the 
presence of 1/xM calcium) induced a higher rate 
of release in all liposomes than 3 mM calcium 
alone. Upon combined drug/calcium challenge, 
the rate was not different from that of calcium 
alone except for PIP2-containing liposomes. In the 
latter case, an intermediate rate was observed. 
The reversibility of the calcium and amino- 
glycoside actions was indicated by the changes in 
the rate of carboxyfluorescein release upon 
sequential addition of calcium and drug (Fig. 2). 
When 1 mM calcium was added after two hours to 
an incubation proceeding with 0.1 mM gentami- 
cin, the rate of carboxyfluorescein release was 
lowered. Conversely, when 0.1 mM gentamicin 
was added after two hours to an incubation pro- 
ceeding with 1 mM calcium, The rate was in- 
creased. 
A comparison of different aminoglycosides (at 
0.1 raM) in the presence of 1 / tM calcium on the 
rate of carboxyfluorescein release (Fig. 3) demon- 
strated three apparent levels of effectiveness: 
Neomycin had the greatest influence on the 
carboxyfluorescein release, (3.6%/h); gentamicin 
and tobramycin each released 2.9%/h; kanamy- 
cin, amikacin, and netilmicin did not act signifi- 
cantly different from each other, each releasing 
around 2.1%/h. The neomycin fragment neamine 
and the aminocyclitol antibiotic spectinomycin 
caused a release slightly above background, 0.9%/ 
h and 0.6%/h, respectively. 
Discussion 
The increase in the rate of carboxyfluorescein 
leakage induced by drugs and calcium can be the 
result of at least three processes: (1) an 'all-or- 
none' rupture of the permeability barrier of a 
portion of the vesicles; (2) cation-induced fusion 
of the liposomes; or (3) alteration of the barrier 
properties of the bilayer leading to an increased 
permeability coefficient of the dye through the 
bilayer. The first mechanism, although theoreti- 
caUy possible if the number of vesicles ruptured 
per unit time is small, seems unlikely since rupture 
can be expected to occur within a short period of 
time [15]. In these experiments, both in the ab- 
sence and presence of cations, the leakage is slow 
(0.2-5%/h) and, more importantly, the rate of 
carboxyfluoreseein release remains essentially con- 
stant for at least 8 hours. The second mechanism 
is not supported by the Tb-DPA studies. This 
sensitive indicator rules out any significant fusion 
under the experimental conditions. Although poly- 
valent cations have been shown to induce lipo- 
some fusion, particularly with small unilamellar 
vesicles [14], our results are in good agreement 
with studies showing that liposomes with more 
than 50 mol% PC are not fused by cations such as 
calcium [16]. Therefore, the increase in the rate of 
carboxyfluorescein leakage induced by calcium 
and the aminoglycosides is a consequence of the 
cations' ability to alter the permeability of the 
bilayer to the dye molecule. 
The ability of the aminoglycosides to affect the 
leakage of the water-soluble indicator depends on 
a number of factors: (i) the lipid composition of 
the liposome; (ii) the concentration of calcium 
present; and (iii) the structure and concentration 
of the aminoglycoside. With respect to the effect 
of lipid composition of the liposome, it is quite 
remarkable that PS, PI and PIP all react alike 
despite differences in structure and charge. In 
contrast to this stands the behavior of PIP2-con- 
taining liposomes which were significantly more 
interactive with aminoglycosides under all condi- 
tions. It should be pointed out that for PIP 2 
liposomes, drug-induced leakiness can be observed 
at antibiotic concentrations as low as 10/~M (Fig. 
1A). 
The uniqueness of PIP 2, which was most strik- 
ing at the higher calcium concentration because 
no other lipid responded to the aminoglycosides, 
is in good agreement with previous studies of 
aminoglycoside-lipid interactions. Recently, Au et 
al. [9] reported that liposomes containing PIP 2 
showed the greatest aminoglycoside-induced mem- 
brane perturbation as measured by changes in 
1-anilino-8-naphthalene sulfonate (ANS) fluores- 
cence when compared to liposomes containing 
other anionic phospholipids (PS, PI or PIP). 
Neomycin also lowered the phase transition tem- 
perature of PIP2-PC liposomes while it raised the 
transition temperature of all other anionic phos- 
pholipid liposomes tested [8]. 
With respect to the influence of calcium on 
aminoglycoside induced leakage, a number of 
points deserve attention. Firstly, carboxyfluor- 
escein release in the presence of aminoglycosides 
was unaffected by the presence of 1/~M calcium. 
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This concentration of calcium approximates bio- 
logical intracellular levels and was considered ap- 
propriate for comparative studies since PIP z is 
believed to reside in the inner bilayers of cyto- 
plasmic membranes [17]. Thus, if aminoglycosides 
are transported into susceptible tissues by an ac- 
tive uptake system as described for the kidney and 
the ear [18], the aminoglycosides will compete 
with low concentrations of calcium. Although the 
aminoglycoside actions are reversible with calcium 
(Fig. 2), the equilibrium will favor the drug/lipid 
binding at intracellular conditions. These conclu- 
sions are also supported by studies [9] showing 
that membrane disturbance by aminoglycoside 
antibiotics as investigated in liposomes containing 
the fluorescent probe, ANS, was unaffected by the 
presence of 1/~M calcium. Since the rate of leakage 
is increased by about one order of magnitude even 
at these low drug concentrations, biological mem- 
branes containing this lipid should be quite sus- 
ceptible to damage by aminoglycosides. 
Recently, we presented a multi-step hypothesis 
of aminoglycoside ototoxicity [19,20] which is con- 
sistent with the data elaborated by our laboratory 
and others: (1) The first step in the proposed 
reaction sequence is an electrostatic interaction of 
the aminoglycoside with negatively charged com- 
ponents of the outer plasma membrane. The re- 
suiting dispalcement of calcium accounts for the 
acute effects of the drug action and is reversible 
and antagonized by cations. (2) The drug is then 
transported into the cell by an energy-dependent 
process. (3) The next and most crucial step is the 
binding of the drug to phosphatidylinositol bis- 
phosphate. The formation of the drug-lipid com- 
plex prevents the hydrolysis of PIP z and thereby 
interferes with its physiological role in the phos- 
phoinositide second messenger system. Further- 
more, it disturbs membrane integrity and struc- 
ture. The data presented in this study show that 
binding of the drug to PIP 2 can in fact result in 
permeability changes of the membrane. Such in- 
creased leakiness in a biological membrane may 
well be a critical factor leading to cell death. 
The excellent correlation (Fig. 4) between the 
ability of different aminoglycosides to affect the 
rate of carboxyfluorescein release from PC:PIP  2 
liposomes (molar ratio 4:1)  and their ototoxicity 
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Fig. 4. Correlation of the effect of aminoglycosides on carbo- 
xyfluorescein (CF) release (shown in Fig. 3) with ototoxicity. 
Ordinate: percentage of carboxyfluorescein release from lipo- 
somes after incubation with 0.1 mM aminoglycosides for 9 
hours. Abscissa: ototoxicity of various aminoglycosides as de- 
termined by chochlear perfusions (see Ref. 10). 1, Spectin- 
omycin; 2, neamine; 3, kanamycin; 4, amikacin; 5, netilmicin; 
6, tobramycin; 7, gentamycin; 8, neomycin. 
ports the contention that drug binding to PIP 2 is 
an integral and decisive step in the mechanism of 
aminoglycoside toxicity. This correlation was simi- 
lar to that reported for the effects of aminoglyco- 
sides on the fluorescence intensity of ANS-con- 
taining liposomes and ototoxicity [10]. The re- 
markable similarity between the two results (ANS 
probes structural changes and carboxyfluorescein 
probes the resultant permeability changes induced 
by the drug) suggests that the drug-PIP 2 interac- 
tion is a quantitative indicator of toxicity and may 
thus be used in in vitro ototoxicity testing. 
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